Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients

Clinical trial NCT04988750 · COMPLETED

Trial details

NCT number: NCT04988750
Sponsor: NaviFUS Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Recurrent Glioblastoma High-Grade Glioma (WHO III-IV)Brain Tumor Recurrent Brain Tumor Adult Brain Tumor, Adult: Glioblastoma Brain Tumor, Recurrent

Start date: 2021-05-23
Primary completion: 2023-06-07
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.